Regulus Therapeutics
RGLS
#6949
Rank
S$0.73 B
Marketcap
S$10.57
Share price
0.00%
Change (1 day)
419.74%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : S$7.51 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are S$7.51 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$10.56 M-16.34%
2023-12-31S$12.62 M-29.82%
2022-12-31S$17.99 M-1.36%
2021-12-31S$18.24 M19.12%
2020-12-31S$15.31 M-48.51%
2019-12-31S$29.74 M-35.54%
2018-12-31S$46.14 M-18.99%
2017-12-31S$56.96 M-11.72%
2016-12-31S$64.52 M168.27%
2015-12-31S$24.05 M-53.87%
2014-12-31S$52.14 M39.01%
2013-12-31S$37.51 M-25.95%
2012-12-31S$50.65 M-53.64%
2011-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
GlaxoSmithKline
GSK
S$79.41 B 1,056,892.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
S$85.56 B 1,138,690.96%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$14.25 B 189,620.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$88.74 B 1,181,083.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
S$5.98 B 79,544.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.10 B 1,321.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.45 B 1,350,175.96%๐Ÿ‡บ๐Ÿ‡ธ USA